Animal Models of Cushing's Syndrome

Abstract

Endogenous Cushing’s syndrome is characterized by unique clinical features and comorbidities, and progress in the analysis of its genetic pathogenesis has been achieved. Moreover, prescribed glucocorticoids are also associated with exogenous Cushing’s syndrome. Several animal models have been established to explore the pathophysiology and develop treatments for Cushing’s syndrome. Here, we review recent studies reporting animal models of Cushing’s syndrome with different features and complications induced by glucocorticoid excess. Exogenous corticosterone (CORT) administration in drinking water is widely utilized, and we found that CORT pellet implantation in mice successfully leads to a Cushing’s phenotype. Corticotropin-releasing hormone (CRH) overexpression mice and adrenal-specific Prkar1a deficient mice have been developed, and AtT20 transplantation methods have been designed to examine the medical treatments for adrenocorticotropic hormone (ACTH)-producing pituitary neuroendocrine tumors. We also review recent advances in the molecular pathogenesis of glucocorticoid-induced complications using animal models.

Assessment of stress levels and reproductive condition in giant pandas: insights from hair, faecal and saliva samples

“…High levels of cortisol secretion, especially if sustained over prolonged periods of time, can result in serious illness ( El-Farhan et al. , 2017 ) such as Cushing’s syndrome ( Nishiyama et al. , 2022 ).…”

Multi-Residue Detection of Eight Glucocorticoids by Nano-Au/Fluticasone Propionate Electrochemical Immunosensor

“…Short-term use of skincare cosmetics containing glucocorticoids can create a false appearance of smooth and tender skin [ 10 ]. However, high-dose or long-term use may cause various adverse reactions, such as Cushing’s syndrome [ 11 ], severe infection [ 12 ], osteoporosis [ 13 ], diabetes [ 14 ], behavioral and cognitive changes, etc. [ 15 , 16 ].…”